Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 540

1.
2.

Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?

Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Niv Y.

Aliment Pharmacol Ther. 2006 Nov 15;24(10):1475-81. Epub 2006 Oct 10.

3.

One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.

Lieberman DA, Weiss DG; Veterans Affairs Cooperative Study Group 380.

N Engl J Med. 2001 Aug 23;345(8):555-60.

4.
5.

Prescreening evaluation of a brush-based faecal immunochemical test for haemoglobin.

Young GP, St John DJ, Cole SR, Bielecki BE, Pizzey C, Sinatra MA, Polglase AL, Cadd B, Morcom J.

J Med Screen. 2003;10(3):123-8.

PMID:
14561263
6.

Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.

Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S, Tichet J, Launoy G.

Gut. 2007 Feb;56(2):210-4. Epub 2006 Aug 4.

7.

A quantitative immunochemical fecal occult blood test for colorectal neoplasia.

Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Leshno M, Niv Y.

Ann Intern Med. 2007 Feb 20;146(4):244-55.

PMID:
17310048
8.

Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.

Tam TK, Ng KK, Lau CM, Lai TC, Lai WY, Tsang LC.

Hong Kong Med J. 2011 Oct;17(5):350-7.

9.

Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia.

Haug U, Kuntz KM, Knudsen AB, Hundt S, Brenner H.

Br J Cancer. 2011 May 24;104(11):1779-85. doi: 10.1038/bjc.2011.160. Epub 2011 May 10.

10.

Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.

Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E, Birkenfeld S, Leshno M, Niv Y.

Aliment Pharmacol Ther. 2009 Apr 15;29(8):906-17. doi: 10.1111/j.1365-2036.2009.03946.x.

12.

Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening.

Parra-Blanco A, Gimeno-García AZ, Quintero E, Nicolás D, Moreno SG, Jiménez A, Hernández-Guerra M, Carrillo-Palau M, Eishi Y, López-Bastida J.

J Gastroenterol. 2010 Jul;45(7):703-12. doi: 10.1007/s00535-010-0214-8. Epub 2010 Feb 17.

PMID:
20157748
13.

Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.

de Wijkerslooth TR, Stoop EM, Bossuyt PM, Meijer GA, van Ballegooijen M, van Roon AH, Stegeman I, Kraaijenhagen RA, Fockens P, van Leerdam ME, Dekker E, Kuipers EJ.

Am J Gastroenterol. 2012 Oct;107(10):1570-8. doi: 10.1038/ajg.2012.249. Epub 2012 Jul 31.

PMID:
22850431
14.

Screening for colorectal cancer using a quantitative immunochemical faecal occult blood test: a feasibility study in an Asian population.

Fu WP, Kam MH, Ling WM, Ong SF, Suzannah N, Eu KW.

Tech Coloproctol. 2009 Sep;13(3):225-30. doi: 10.1007/s10151-009-0515-1. Epub 2009 Jul 23.

PMID:
19629380
15.

Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.

Bampton PA, Sandford JJ, Cole SR, Smith A, Morcom J, Cadd B, Young GP.

Gut. 2005 Jun;54(6):803-6.

16.

Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test.

Fenocchi E, Martínez L, Tolve J, Montano D, Rondán M, Parra-Blanco A, Eishi Y.

Eur J Cancer Prev. 2006 Oct;15(5):384-90.

PMID:
16912566
17.

Faecal haemoglobin concentration is related to severity of colorectal neoplasia.

Digby J, Fraser CG, Carey FA, McDonald PJ, Strachan JA, Diament RH, Balsitis M, Steele RJ.

J Clin Pathol. 2013 May;66(5):415-9. doi: 10.1136/jclinpath-2013-201445. Epub 2013 Feb 15.

PMID:
23418340
18.

Colonoscopy requirements of population screening for colorectal cancer in New Zealand.

Green T, Richardson A, Parry S.

N Z Med J. 2012 Jun 8;125(1356):85-95.

PMID:
22729063
19.

A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.

Levi Z, Hazazi R, Rozen P, Vilkin A, Waked A, Niv Y.

Aliment Pharmacol Ther. 2006 May 1;23(9):1359-64. Erratum in: Aliment Pharmacol Ther. 2006 Sep 1;24(5):895.

20.

Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia.

Regula J, Rupinski M, Kraszewska E, Polkowski M, Pachlewski J, Orlowska J, Nowacki MP, Butruk E.

N Engl J Med. 2006 Nov 2;355(18):1863-72.

Items per page

Supplemental Content

Write to the Help Desk